Minkwon Cho

Title: The Innovations of Minkwon Cho

Introduction

Minkwon Cho is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of seven patents to his name, Cho's work has had a substantial impact on medical research and therapeutic applications.

Latest Patents

Among his latest patents is a groundbreaking invention related to polynucleotides encoding anti-human receptor-type protein tyrosine phosphatase sigma antibodies. This monoclonal antibody binds to an extracellular domain of human receptor-type protein tyrosine phosphatase σ (human PTPRS), or a fragment including an antigen-binding region thereof. Another notable patent involves methods of using anti-phospholipase D4 antibodies, which bind to a phospholipase D4 (PLD4) protein, or a fragment containing an antigen-binding region thereof. These innovations showcase Cho's expertise in antibody development and its potential applications in treating various diseases.

Career Highlights

Minkwon Cho has worked with several reputable companies throughout his career. Notably, he has been associated with Sbi Biotech Co., Ltd. and Chugai Seiyaku Kabushiki Kaisha. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in biotechnology.

Collaborations

Throughout his career, Cho has collaborated with esteemed colleagues, including Koji Ishida and Tomohide Yamazaki. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field.

Conclusion

Minkwon Cho's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to influence the development of therapeutic antibodies, paving the way for future innovations.